Norisha Quinones
Family · Maitland, FLNPI 1043728934
Payments from drug & device makers
Across 52 payments — averaging $107.19 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$706
- Neurocrine Biosciences, Inc.$483
- Novo Nordisk$444
- Grifols USA, LLC$252
- Gilead$245
- Teva Pharmaceuticals USA, Inc.$231
- plus $3K from 26 others
What the payments were for
- Speaking & faculty fees$1002%
- Food & beverage$5,47398%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca | 6 | $706 |
| Neurocrine Biosciences, Inc. | 4 | $483 |
| Novo Nordisk | 4 | $444 |
| Grifols USA, LLC | 2 | $252 |
| Gilead | 2 | $245 |
| Teva Pharmaceuticals USA, Inc. | 2 | $231 |
| Viiv Healthcare Company | 3 | $229 |
| Paratek Pharmaceuticals, Inc. | 2 | $226 |
| Coloplast | 2 | $174 |
| Sanofi-aventis U.S. LLC | 2 | $171 |
| Medtronic | 2 | $158 |
| Abiomed | 1 | $133 |
| Shield Therapeutics Inc | 1 | $125 |
| Amgen | 1 | $125 |
| Sanofi | 1 | $122 |
| Kyowa Kirin, Inc. | 1 | $120 |
| Apellis Pharmaceuticals, Inc. | 1 | $120 |
| Kerecis Limited | 1 | $119 |
| Janssen Products, LP | 1 | $117 |
| Axsome Therapeutics, Inc. | 1 | $117 |
| Astellas Pharma US Inc | 1 | $112 |
| Biogen | 1 | $107 |
| Novartis | 1 | $106 |
| Silk Road Medical, Inc. | 1 | $104 |
| Eisai Inc. | 1 | $103 |
| Genentech USA, Inc. | 1 | $102 |
| Medicure Pharma Inc. | 1 | $100 |
| Insmed, Inc. | 1 | $93 |
| GSK | 1 | $92 |
| Boston Scientific | 1 | $91 |
| Atricure, Inc. | 1 | $79 |
| Bayer | 1 | $67 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- INGREZZA$483
- Kerecis Omega3 Marigen$476
- BREZTRI$256
- Prolastin-C Liquid$252
- Epclusa$245
- AIRSUPRA$229
- NUZYRA$226
- Wegovy$221
- ENROUTE Transcarotid Neuroprotection System$207
- Austedo XR$131
- ACCRUFER$125
- RUKOBIA$125
- UPLIZNA$125
- FABRAZYME$122
- FARXIGA$122
- CRYSVITA$120
- Empaveli$120
- Kerecis Omega3 SurgiClose$119
- Symtuza$117
- Auvelity$117
How this compares
$5,574 in reported general payments places this provider in the 90th percentile of 14,618 family providers in Florida.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Daptomycin | 26 | $10,916 |
| ErtapenemErtapenem Sodium | 17 | $9,610 |
| CeftriaxoneCeftriaxone Sodium | 16 | $2,610 |
| Linezolid | 15 | $871 |
| Cefepime Hcl | 12 | $631 |
| Cefdinir | 48 | $516 |
| Fluconazole | 24 | $223 |
| CefuroximeCefuroxime Axetil | 14 | $196 |
| Ciprofloxacin Hcl | 21 | $157 |
| Doxycycline Hyclate | 21 | $149 |
| Methylprednisolone | 15 | $110 |
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 14 | $80 |
| Levofloxacin | 24 | $68 |
Paid to pharmacies, not to this prescriber.
Other family in Maitland
- Deena RodneyMaitland$323K
- John HuffakerVenice$8M
- Stephanie MompointMiami$4.5M
- Miguel TrujilloMiami Gardens$4.4M
- Itsel Cardenas RamonMiami$1M
- Lewis HarringtonTampa$954K
- Adam StrosbergFort Lauderdale$859K
- Danielle PharesFt Lauderdale$713K
- David RodriguezHialeah$658K
- Donna OrtizOrlando$417K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.